Compare CBLL & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CBLL | LDP |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | 280 | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 750.1M | 606.3M |
| IPO Year | N/A | N/A |
| Metric | CBLL | LDP |
|---|---|---|
| Price | $21.16 | $20.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $23.20 | N/A |
| AVG Volume (30 Days) | ★ 227.5K | 71.7K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.57 | N/A |
| Revenue Next Year | $28.44 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.85 | $19.35 |
| 52 Week High | $24.33 | $22.05 |
| Indicator | CBLL | LDP |
|---|---|---|
| Relative Strength Index (RSI) | 65.01 | 54.41 |
| Support Level | $20.39 | $20.42 |
| Resistance Level | $22.49 | $21.47 |
| Average True Range (ATR) | 0.72 | 0.23 |
| MACD | 0.24 | 0.04 |
| Stochastic Oscillator | 86.82 | 64.08 |
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.